Tuberculosis vaccine candidate: Characterization of H4-IC31 formulation and H4 antigen conformation

Deshmukh, SS; Magcalas, FW; Kalbfleisch, KN; Carpick, BW; Kirkitadze, MD

Kirkitadze, MD (reprint author), Sanofi Pasteur Ltd, 1755 Steeles Ave West, Toronto, ON M2R 3T4, Canada.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018; 157 (): 235

Abstract

Tuberculosis (TB) is one of the leading causes of death worldwide, making the development of effective TB vaccines a global priority. A TB vaccine con......

Full Text Link